Concepedia

Amellie Lusque

AL

Statistics

Publications

3

Citations

96

H-Index

3

Active since

2018

Affiliations

Hôpital Larrey(Current)

Institut universitaire du cancer de Toulouse Oncopole

University Health Network

Memorial Sloan Kettering Cancer Center

University of Lucerne

Amellie Lusque is an author at Hôpital Larrey specializing in cancer research, medicine, and pathology.

Top concepts

Publications per year

2018–2018

3

Publications

3

Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations (ImmunoTarget).

Julien Mazieres, Alexander Drilon, Laurent Mhanna et al. · Journal of Clinical Oncology · 2018 · 54 citations

, , +19

Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.

Laurent Mhanna, Julie Milia, Amellie Lusque et al. · Journal of Clinical Oncology · 2018 · 31 citations

, , +20

Baseline circulating myeloid-derived suppressor cells and response to PD-1 inhibitor in non-small cell lung cancer patients.

Myriam Delaunay, Nicolas Guibert, Amellie Lusque et al. · Journal of Clinical Oncology · 2018 · 11 citations

, , +19

1–3 of 3